An industrial production process for biphenyl-substituted chiral amino alcohols
By combining a continuous flow microchannel reactor with a pre-designed catalytic oxidation system, and using Lewis acid catalysis and phase transfer catalysts, the problem of quality instability in the production of biphenyl-substituted chiral amino alcohols was solved, achieving high yield and high purity of the target product, meeting the quality requirements of the active pharmaceutical ingredient.
Patent Information
- Application Number
- CN202611623653.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-10-20
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies for the industrial production of biphenyl-substituted chiral amino alcohols suffer from problems such as excessive oxidation of primary hydroxyl groups to generate carboxylic acid byproducts, easy racemization of chiral centers, isomer contamination, and excessive residues of heavy metals and chloride ions, resulting in unstable product quality and low yield.
Selective oxidation is achieved by using a continuous flow microchannel reactor combined with a pre-set catalytic oxidation system. The Lewis acid-catalyzed mild homogenization reaction is used, the phase transfer catalyst controls the direction of the condensation reaction, and the enantiomeric excess value and purity are controlled by the deprotection reaction under acidic conditions.
This improved the yield and purity of biphenyl-substituted chiral amino alcohols, meeting the standards for active pharmaceutical ingredients, while reducing wastewater discharge and solvent consumption, thus enhancing production stability and efficiency.
Smart Images

Figure CN123106449A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of pharmaceutical intermediate production technology, and in particular to an industrial production process for biphenyl-substituted chiral amino alcohols. Background Technology
[0002] These biphenyl-substituted chiral amino alcohols serve as key intermediates in the synthesis of various active pharmaceutical ingredients (APIs). Their purity and chiral quality directly determine the efficacy and safety of downstream drugs, holding an irreplaceable position in the production of cardiovascular, anti-inflammatory, and nervous system drugs. With regulatory authorities tightening their requirements for API impurity profiles and residue indicators, the large-scale preparation processes for these compounds are becoming a crucial hurdle to overcome in the integration of the fine chemical and pharmaceutical industries.
[0003] For a long time, the industry has generally followed the traditional method of batch reactors, which involves sequentially feeding, heating, holding, and cooling the material in a large reactor. This method can barely meet the needs in the laboratory stage, but once scaled up to industrial scale, it becomes problematic because uneven temperature inside the reactor, delayed material mixing, and difficulty in precisely controlling the reaction time leave a large number of byproducts and impurities at each step of the reaction. This ultimately leads to significant fluctuations in product quality between batches, and the yield remains at a low level for a long time.
[0004] What truly challenges process engineers is that multiple reaction steps in the entire synthetic chain are mutually constraining, like dominoes. The root of this constraint points to the same technical factor: a lack of precise control over residence time and local environments. In the step of oxidizing the primary hydroxyl group on the starting material molecule to an aldehyde group, even a slight delay will cause the aldehyde group to be further oxidized into an unwanted carboxylic acid, rendering the next step impossible. In the homologation step, which extends the carbon chain by one lattice, even minor deviations in reaction temperature and acid-base conditions can cause the chiral center, which determines the direction of efficacy, to flip, generating a mirror-image structure of impurities that render the product ineffective. The subsequent cyclization reaction must be carried out between two immiscible liquids, with two possible isomers forming almost simultaneously under the same conditions, resulting in a low proportion of the target product in the mixture. Finally, in the step of removing the protecting group, if a crude approach using strong acids and metal reagents is employed, heavy metal ions and chloride ions will remain in the product, exceeding pharmacopoeia limits.
[0005] Therefore, how to solve the interconnected problems of over-oxidation, chiral reversal, isomer contamination, and excessive residues on the same industrial production line, so that the yield, optical purity, and impurity level of the target product can simultaneously meet the requirements of the active pharmaceutical ingredient, has become the key issue to promote the large-scale clean production of this compound. Summary of the Invention
[0006] This invention provides an industrial production process for biphenyl-substituted chiral amino alcohols, mainly comprising: A chiral amino alcohol containing a biphenyl group and a tert-butyl carbamate protecting group is obtained as a starting material. The starting material is fed into a continuous flow microchannel reactor, and the primary hydroxyl group of the starting material is selectively oxidized through a preset catalytic oxidation system to obtain an aldehyde intermediate. A diazonium acetate compound is obtained, and the aldehyde intermediate is homogenized with the diazonium acetate compound under Lewis acid catalysis to obtain a betaketone ester intermediate. A hydrazine compound is obtained, and the betaketone ester intermediate is condensed with the hydrazine compound in a two-phase system consisting of an aqueous phase and an organic phase through a phase transfer catalyst to obtain a condensation intermediate with a tert-butyl carbamate protecting group. The condensation intermediate with the tert-butyl carbamate protecting group is deprotected under acidic conditions to obtain the target product.
[0007] Furthermore, the selective oxidation of the primary hydroxyl group of the starting material to obtain the aldehyde intermediate through a preset catalytic oxidation system includes: obtaining tetramethylpiperidine nitride, hypochlorite, and bromide to construct the catalytic oxidation system; controlling the input of the starting material and the catalytic oxidation system into the mixing section of the continuous flow microchannel reactor to obtain a mixed liquid; controlling the mixed liquid in the reaction residence section of the continuous flow microchannel reactor within a preset temperature range, and controlling the residence time of the mixed liquid in the reaction residence section to reach a preset time threshold; obtaining the reacted liquid from the outlet of the continuous flow microchannel reactor, determining the stratification state of the liquid, and if the liquid exhibits a two-phase separation state, performing stratification treatment on the liquid to obtain an organic phase, and washing, drying, and concentrating the organic phase to determine the aldehyde intermediate.
[0008] Furthermore, the process of homogenizing the aldehyde intermediate with the diazonium acetate ester compound under Lewis acid catalysis to obtain the betaketone ester intermediate includes: obtaining at least one of boron trifluoride diethyl ether complex, zinc chloride, or tin tetrachloride as the Lewis acid; dissolving the aldehyde intermediate in a preset organic solvent under anhydrous conditions to obtain a first solution; adding the Lewis acid to the first solution to obtain a second solution; adding a solution of the diazonium acetate ester compound dropwise to the second solution, controlling the temperature of the dropwise addition process to be below a preset first temperature threshold; raising the temperature to a preset second temperature threshold after the dropwise addition is completed and maintaining the temperature for the reaction, judging the conversion rate of the reaction system, and if the conversion rate reaches a preset conversion rate threshold, adding an alkaline solution for quenching, separating and identifying the betaketone ester intermediate.
[0009] Furthermore, in the two-phase system consisting of an aqueous phase and an organic phase, the betaketone ester intermediate undergoes a condensation reaction with the hydrazine compound using a phase transfer catalyst to obtain a condensation intermediate with a tert-butyl carbamate protecting group. This process includes: obtaining at least one of tetrabutylammonium bromide, benzyltriethylammonium chloride, or octadecanoic acid as the phase transfer catalyst; obtaining toluene or xylene as the organic phase; obtaining an alkaline aqueous solution containing sodium carbonate or potassium carbonate as the aqueous phase; mixing the betaketone ester intermediate with the organic phase, the phase transfer catalyst, and the aqueous phase to obtain a mixed system; heating the mixed system to a preset third temperature threshold; adding the hydrazine compound, specifically hydrazine hydrate, dropwise to the mixed system at the third temperature threshold; maintaining the temperature at the third temperature threshold after the addition is complete; determining the isomer ratio of the reaction system; if the isomer ratio reaches a preset ratio threshold, separating the organic phase; washing, drying, and concentrating the separated organic phase to determine the condensation intermediate with the tert-butyl carbamate protecting group.
[0010] Furthermore, the step of deprotecting the condensation intermediate with the tert-butyl carbamate protecting group under acidic conditions to obtain the target product includes: constructing the acidic conditions by obtaining an ethyl acetate solution of hydrogen chloride or an ethanol solution of p-toluenesulfonic acid; dissolving the condensation intermediate with the tert-butyl carbamate protecting group in a preset reaction solvent to obtain a third solution; introducing the ethyl acetate solution of hydrogen chloride or the ethanol solution of p-toluenesulfonic acid into the third solution to obtain a fourth solution; controlling the fourth solution to be stirred at a preset fourth temperature threshold; judging the reaction progress of the fourth solution; if the reaction is completed, the fourth solution is concentrated under reduced pressure to remove excess acidic substances, water is added and the pH is adjusted to weakly alkaline using an alkaline reagent, and a crude product is obtained by extraction, drying and concentration; the crude product is recrystallized to determine the target product.
[0011] Furthermore, the step of performing a phase separation process on the feed liquid to obtain an organic phase, and then washing, drying, and concentrating the organic phase to determine the aldehyde intermediate includes: controlling the feed liquid to be fed into a phase separator and allowing it to stand and separate into a first organic phase and a first aqueous phase; using an extractant to perform countercurrent extraction on the first aqueous phase to obtain a second organic phase; combining the first organic phase and the second organic phase to obtain a third organic phase; washing the third organic phase with sodium thiosulfate solution, and then washing the washed third organic phase again with brine; drying the washed third organic phase with anhydrous sodium sulfate, and then concentrating the dried third organic phase under reduced pressure to determine the aldehyde intermediate.
[0012] Furthermore, the step of washing, drying, and concentrating the separated organic phase to determine the condensation intermediate with the tert-butyl carbamate protecting group includes: extracting the aqueous phase after the reaction using a preset extraction solvent to obtain a supplementary organic phase; combining the separated organic phase and the supplementary organic phase to obtain a total organic phase; washing the total organic phase with saturated brine to obtain a washed organic phase; drying the washed organic phase with a desiccant to obtain a dried organic phase; concentrating the dried organic phase under reduced pressure to obtain a crude solid product; and recrystallizing the crude solid product using a mixed solvent of ethanol and water to determine the condensation intermediate with the tert-butyl carbamate protecting group.
[0013] Furthermore, the step of adding an alkaline solution for quenching, separating and identifying the betaketone ester intermediate includes: obtaining a saturated sodium bicarbonate solution as the alkaline solution; controlling the addition of the saturated sodium bicarbonate solution to the system after the reaction for mixing and quenching to obtain a quenched mixture; allowing the quenched mixture to stand and separate into layers, separating the upper aqueous phase and the lower organic phase; using dichloromethane to extract the upper aqueous phase multiple times to obtain an extracted organic phase; combining the lower organic phase and the extracted organic phase to obtain a combined organic phase; washing, drying and concentrating the combined organic phase; and removing low-boiling-point impurities by short-path distillation to identify the betaketone ester intermediate.
[0014] The technical solutions provided by the embodiments of the present invention may include the following beneficial effects: This invention discloses an industrial production process for biphenyl-substituted chiral amino alcohols. Addressing the intertwined industrialization challenges of traditional batch reactor synthesis routes, such as excessive oxidation of primary hydroxyl groups to generate carboxylic acid byproducts, racemization of chiral centers during homologation, difficulty in controlling isomer ratios in the condensation step, and excessive heavy metal and chloride ion residues after deprotection, this invention combines a continuous flow microchannel reactor with a pre-defined catalytic oxidation system. This allows for precise control of residence time within a low-temperature, narrow window to achieve selective oxidation of the primary hydroxyl group to the aldehyde group. Subsequently, under anhydrous conditions, a Lewis acid is introduced to catalyze a mild insertion homologation reaction between the aldehyde intermediate and diazonium acetate to maintain the chiral configuration. A phase-transfer catalyst is then used to regulate the condensation reaction direction of hydrazine compounds in a two-phase system to enrich the target isomer. Finally, the protecting group of tert-butyl carbamate is mildly removed under acidic conditions, and recrystallization controls the crystal form. This process consistently increases the overall yield to over 65%, achieving product purity and enantiomeric excess values that meet pharmaceutical-grade standards. Simultaneously, wastewater discharge is significantly reduced, and solvent recycling is achieved. Attached Figure Description
[0015] Figure 1 A flowchart of an industrial production process for biphenyl-substituted chiral amino alcohols according to the present invention; Figure 2 This is a flowchart of step S1 of the present invention; Figure 3 This is a flowchart of step S2 of the present invention; Figure 4 This is a flowchart of step S3 of the present invention; Figure 5 This is a flowchart of step S4 of the present invention; Figure 6 This is a flowchart of step S5 of the present invention. Detailed Implementation
[0016] To further understand the content of this invention, a detailed description of the invention is provided in conjunction with the accompanying drawings and embodiments. The specific embodiments described herein are for illustrative purposes only and are not intended to limit the invention. It should also be noted that, for ease of description, only the parts relevant to the invention are shown in the accompanying drawings.
[0017] like Figures 1-6 The industrial production process of a biphenyl-substituted chiral amino alcohol in this embodiment may specifically include: This invention provides an industrial production process for biphenyl-substituted chiral amino alcohols. Figure 1 This is a schematic flow chart of the industrial production process of biphenyl-substituted chiral amino alcohols provided in the embodiments of the present invention, as shown below. Figure 1 As shown, the process includes: Step S1 involves obtaining a chiral amino alcohol containing a biphenyl group and a tert-butyl carbamate protecting group as a starting material. Here, the starting material refers to the initial feedstock of the entire industrial synthesis route, whose molecular structure simultaneously possesses a biphenyl group, a tert-butyl carbamate protecting group, and at least one chiral center. This structure is chosen as the starting point because the biphenyl group acts as a rigid framework in the subsequent drug molecule, providing spatial configuration stability for the final target product. The tert-butyl carbamate protecting group safeguards the amino functional group from destruction by intermediate reactions throughout the synthesis route, preventing side reactions, and allows for easy removal at the end under acidic conditions, restoring the active amino group. The presence of the chiral center ensures the product has a single configuration, avoiding the interference of diastereomers on purity and efficacy. In one possible implementation, the starting material can be obtained from commercially available reagents or prepared internally through a preceding chiral synthesis route. If purchased externally, the raw materials must undergo quality inspection upon arrival at the factory before being fed into the production line. The inspection items include melting point range, specific rotation, liquid chromatography purity, moisture content, and heavy metal residues. Only materials that pass all inspections are allowed to be fed into the main production line. If an internal synthesis method is used, biphenylaldehyde is typically used as the starting material. A chiral amino group is first introduced through a chiral catalytic reductive amination reaction. Then, di-tert-butyl dicarbonate is used to protect the amino group under sodium bicarbonate aqueous phase conditions. Finally, the carboxyl or ester group is reduced with sodium borohydride to obtain a primary hydroxyl group, resulting in an amino alcohol structure containing a biphenyl group, a tert-butyl carbamate protecting group, and a chiral center. Specifically, the moisture content of the starting material must be controlled before feeding, typically requiring a moisture content below 0.5%. Excessive moisture content can affect the activity of the catalytic oxidation system in subsequent steps and may cause quenching reactions with Lewis acid catalysts. For example, azeotropic distillation can be used for dehydration, where an appropriate amount of toluene is added to the raw material, and the water is removed by vacuum distillation until no more water drips from the top of the column. After pretreatment, the starting materials are stored in nitrogen-protected tanks in solid or concentrated solution form, awaiting entry into the next process. It is important to note that the quality of the starting materials has a decisive impact on the yield and purity of the entire synthetic route. If enantiomers of non-target configurations remain in the starting materials, they will be retained in each subsequent reaction step, ultimately leading to a decrease in the optical purity of the product. Therefore, in actual production, the enantiomer excess of the starting materials is typically required to be no less than 99% to ensure that the chiral purity of the end product meets the requirements for drug substance grade.
[0018] Step S2 involves controlling the input of the starting material into a continuous flow microchannel reactor. The primary hydroxyl group of the starting material is selectively oxidized using a pre-set catalytic oxidation system to obtain an aldehyde intermediate. The reason for using a continuous flow microchannel reactor instead of a traditional batch reactor is that the oxidation of the primary hydroxyl group to the aldehyde group is a strongly exothermic reaction and is very prone to over-oxidation to form carboxylic acids. If the temperature is not properly controlled or the mixing is uneven, a large amount of carboxylic acid byproducts will be mixed into the product, preventing subsequent steps from proceeding normally. The continuous flow microchannel reactor features a large heat exchange area, high mixing efficiency, and precise control of residence time, enabling the reaction process to be stabilized within the window of selective aldehyde formation, thereby suppressing over-oxidation. In one possible implementation, step S2 specifically includes the following sub-steps: Step S21 involves obtaining tetramethylpiperidine nitride oxide, hypochlorite, and bromide to construct a catalytic oxidation system. Tetramethylpiperidine nitride oxide acts as the oxidation catalyst in this process. Its active form is a nitrogen-oxygen cation, which can selectively abstract hydrogen from primary hydroxyl groups to generate the corresponding aldehyde group. Hypochlorite, typically sodium hypochlorite, is the main oxidant, used to re-oxidize the deactivated hydroxylamine form back to nitrogen-oxygen cations, thereby maintaining the catalytic cycle. Potassium bromide or sodium bromide is typically chosen as the bromide. Its role is to generate trace amounts of hypobromic acid intermediates, accelerating the re-oxidation process of tetramethylpiperidine nitride oxide by hypochlorite and increasing the reaction rate. The molar ratio of the three components is typically controlled between 1% and 5% of the starting material for the catalyst, with hypochlorite controlled at 1.05 to 1.2 times the molar amount of the starting material, and bromide controlled at approximately 10%.
[0019] Step S22 involves controlling the mixing of the starting material and the catalytic oxidation system in the mixing section of a continuous flow microchannel reactor to obtain a mixed liquid. For example, the starting material is pre-dissolved in dichloromethane to form an organic phase solution, while the hypochlorite and bromide in the catalytic oxidation system are dissolved in a sodium bicarbonate buffer solution to form an aqueous phase solution. Both phase solutions are injected into the T-type mixing module of the microchannel reactor via high-precision metering pumps at set flow rates, achieving rapid emulsification and mixing within the microchannels to form a finely dispersed liquid-liquid emulsion. Tetramethylpiperidine nitrogen oxides can be pre-dissolved in the organic phase and introduced together, or they can be injected separately into the mixing section via a third branch.
[0020] Step S23 involves controlling the mixture within a preset temperature range in the reaction residence section of the continuous flow microchannel reactor, and controlling the residence time of the mixture in the reaction residence section to reach a preset time threshold. The reaction residence section typically consists of multiple microchannel modules connected in series, each with an independent heat exchange jacket. A cooling medium is introduced to maintain the reaction temperature between 0°C and 10°C. The temperature is controlled within a low-temperature window because the oxidation reaction itself is highly exothermic, and a low-temperature environment helps suppress the side reaction of further oxidation of the aldehyde group to carboxylic acid. The residence time is typically controlled between three and ten minutes, with the specific value calculated based on the material flow rate and microchannel volume. If the residence time is too short, the initial raw material conversion is incomplete, leaving a large amount of unreacted alcohol in the material; if the residence time is too long, the aldehyde product begins to be over-oxidized. For example, when the total material flow rate is 100 ml / min and the total volume of the reaction residence section is 500 ml, the actual residence time is five minutes. At this time, the conversion rate can typically reach over 98% by online infrared or liquid phase sampling monitoring.
[0021] Step S24: Obtain the reacted liquid from the outlet of the continuous flow microchannel reactor, determine the stratification state of the liquid. If the liquid exhibits two-phase separation, perform stratification treatment to obtain the organic phase. Wash, dry, and concentrate the organic phase to identify the aldehyde intermediate. The reacted liquid enters a settling tank at the outlet. Due to the density difference between the aqueous phase and the dichloromethane organic phase, clear stratification usually occurs within 30 seconds to 2 minutes. If the liquid exhibits emulsification without stratification, it indicates that excessive surfactant components were introduced during mixing or that the product structure has an emulsification tendency. In this case, adding a small amount of salt to break the emulsion or moderately heating to below 30 degrees Celsius can promote stratification. Further, the stratification and post-treatment in step S24 specifically includes the following sub-steps: Step S241: Control the feed liquid to be fed into the separator for settling and separation, separating the first organic phase and the first aqueous phase. The separator is usually a continuous settling tank equipped with a level gauge and an interface detector, which can automatically switch the discharge valve according to the interface height to transport the lower organic phase and the upper aqueous phase to different intermediate storage tanks.
[0022] Step S242 involves countercurrent extraction of the first aqueous phase using an extractant to obtain the second organic phase. The extractant here is typically dichloromethane, the same solvent used in the main reaction, to avoid introducing a new solvent system that could hinder recovery. Countercurrent extraction is achieved through a multi-stage mixing and clarification tank or a packed tower, generally with three to five stages, which can increase the recovery rate of residual products in the aqueous phase to over 99%.
[0023] Step S243: Combine the first organic phase and the second organic phase to obtain the third organic phase. The combined third organic phase contains the target aldehyde intermediate, a small amount of tetramethylpiperidine oxynitride catalyst residue, trace amounts of hypochlorite decomposition products, and solvated bromide ions.
[0024] Step S244 involves washing the third organic phase with sodium thiosulfate solution, followed by a second washing with brine. The sodium thiosulfate solution is typically prepared as a 10% (w / w) aqueous solution. Its function is to reduce residual active chlorine and hypobromic acid in the organic phase to non-oxidizing chlorides and bromides, preventing these residual oxidants from further oxidizing aldehyde groups during subsequent storage or transportation. The brine washing removes residual water-soluble salts and trace amounts of catalyst from the organic phase, while also reducing its water content. Exemplarily, sodium thiosulfate washing is typically performed twice, each time using one-third of the organic phase volume, and the brine washing is performed once, using half the organic phase volume.
[0025] Step S245 involves drying the third organic phase after re-washing with anhydrous sodium sulfate, followed by vacuum concentration to determine the aldehyde intermediate. The amount of anhydrous sodium sulfate is typically 10% of the organic phase mass. After addition, the mixture is stirred for at least 30 minutes, and then filtered to remove the water-absorbed sodium sulfate solid. The filtrate is then fed into a falling film evaporator or rotary evaporator and concentrated under reduced pressure at a vacuum of 0.08 MPa and a water bath temperature of 35°C until the solvent is completely evaporated, yielding a pale yellow oily or light-colored solid aldehyde intermediate. The aldehyde intermediate should not be stored for extended periods and is typically introduced into the next reaction within 24 hours of its preparation. For short-term storage, it should be placed in a nitrogen-protected environment at -20°C. Understandably, the selective oxidation of primary hydroxyl groups using a continuous flow microchannel reactor can shorten the reaction time from several hours to a few minutes compared to the traditional batch reactor process, increase the product yield from about 80% to over 95%, and significantly reduce the proportion of carboxylic acid byproducts, providing higher purity raw materials for subsequent homogenization reactions and fundamentally ensuring the stability of the entire synthetic route.
[0026] Step S3 involves obtaining a diazonium acetate ester compound. Under Lewis acid catalysis, the aldehyde intermediate undergoes a homologation reaction with the diazonium acetate ester compound to obtain a betaketone ester intermediate. Here, homologation refers to a reaction in which a carbon atom is inserted into a carbonyl compound via a diazonium compound, thereby extending the carbon chain by one position and forming a new active functional group. In this process, the diazonium acetate ester compound provides a carbon unit with an ester group, which is inserted between the aldehyde group and the adjacent biphenyl-substituted carbon, ultimately yielding a betaketone ester structure containing a ketone carbonyl group and an ester group forming a 1:3 relationship. This route was chosen instead of the traditional ester condensation reaction because the aldehyde intermediate is adjacent to a chiral center, and basic condensation conditions easily cause racemization of the chiral center. Lewis acid-catalyzed homologation reactions, however, fall into this category. In this process, ethyl diazonoacetate is typically chosen as the ester compound, but methyl diazonoacetate or tert-butyl diazonoacetate can also be used, depending on the compatibility with the ester group removal conditions in subsequent steps. Ethyl diazonoacetate is a commercially available yellow liquid with a certain degree of explosive sensitivity. Therefore, heating, impact, and contact with strong acids and bases should be avoided during storage and use. It is usually prepared as a low-concentration dichloromethane solution, with the concentration controlled between 10% and 15% by mass, to ensure reaction efficiency while reducing operational risks. In one possible implementation, step S3 specifically includes the following sub-steps: Step S31: Obtain at least one of boron trifluoride diethyl ether complex, zinc chloride, or tin tetrachloride as a Lewis acid. Boron trifluoride diethyl ether complex is a commonly used liquid Lewis acid with strong acidity and good solubility, capable of rapidly coordinating with the oxygen atom in the aldehyde group to activate the carbonyl group. Zinc chloride is a mild solid Lewis acid with slightly lower activity than boron trifluoride but better selectivity, suitable for applications requiring high stability of the reaction system. Tin tetrachloride has Lewis acidity between the two and can suppress the self-decomposition side reaction of diazo compounds at low temperatures. In actual production, boron trifluoride diethyl ether complex is usually preferred, with its dosage controlled between 10% and 30% of the molar amount of the aldehyde intermediate; this is a catalytic amount rather than a stoichiometric amount.
[0027] Step S32: Under anhydrous conditions, the aldehyde intermediate is dissolved in a pre-selected organic solvent to obtain a first solution. The organic solvent here is typically dichloromethane, but dichloroethane or diethyl ether can also be used. The common requirement is that it be an anhydrous, neutral solvent free of active hydrogen, capable of dissolving the aldehyde intermediate without reacting with it. The emphasis on anhydrous conditions is because if even a trace amount of water is introduced into the system, the Lewis acid will coordinate with water to form a protic acid, leading to catalyst deactivation and potentially initiating hydration and self-condensation of the aldehyde group. For example, the dichloromethane needs to be dried using a molecular sieve or calcium hydride before use, with the water content controlled to below 50 parts per million. The solution is prepared by adding 10 ml of dichloromethane per gram of aldehyde intermediate, stirring to dissolve, and then transferring it to a nitrogen-protected reaction vessel for later use.
[0028] Step S33: Add a Lewis acid to the first solution to obtain the second solution. The addition process needs to be carried out at low temperature and under stirring. Typically, the reactor is pre-cooled to below -10 degrees Celsius, and then the boron trifluoride diethyl ether complex is slowly added through a constant-pressure dropping funnel. During the addition process, there will be slight exothermic activity and a color change in the solution, from colorless to pale yellow. This is a characteristic of the Lewis acid coordinating with the aldehyde carbonyl oxygen to form an activated intermediate. After the addition is complete, continue stirring at low temperature for ten to twenty minutes to allow the system to fully equilibrate.
[0029] Step S34: A solution of diazonium acetate compounds is added dropwise to the second solution, with the temperature during the dropwise addition process controlled below a preset first temperature threshold. For example, the first temperature threshold is typically set to -10 degrees Celsius, and the system temperature is maintained above this threshold during the dropwise addition process using a jacketed chilled brine or dry ice-ethanol bath. Controlling the dropwise rate is crucial. If the dropwise addition is too fast, the diazonium acetate will decompose due to excessively high local concentrations, releasing nitrogen gas and generating maleate ester byproducts. If the dropwise addition is too slow, the overall reaction time will be too long, affecting production efficiency. Typically, the dropwise addition time is controlled between one and two hours, during which fine nitrogen bubbles are continuously observed in the reaction system, indicating that the diazonium groups are participating in the homogenization reaction according to the expected pathway.
[0030] Step S35: After the addition is complete, the temperature is raised to a preset second temperature threshold for heat preservation reaction. The conversion rate of the reaction system is judged. If the conversion rate reaches the preset conversion rate threshold, an alkaline solution is added for quenching, and the beta-ketone ester intermediate is separated and identified. The second temperature threshold is usually set between 0°C and 10°C, and the heat preservation reaction time is two to four hours. During this period, samples are taken every thirty minutes for liquid chromatography monitoring to determine the residual proportion of the aldehyde intermediate. When the residual amount of the aldehyde intermediate drops to below 2%, it is considered that the conversion rate has reached the preset threshold, and the quenching process can proceed. Further, the quenching and separation process in step S35 includes the following sub-steps: Step S351: Obtain a saturated sodium bicarbonate solution as an alkaline solution. The reason for choosing a saturated sodium bicarbonate solution is that it is weakly alkaline and can gently neutralize the Lewis acids in the system without hydrolyzing and destroying the ester or ketone carbonyl groups. At the same time, the carbon dioxide released by the reaction can be directly discharged in the gas phase, avoiding accumulation in the liquid phase and causing violent turbulence in the system.
[0031] Step S352: A saturated sodium bicarbonate solution is added to the system after the reaction is complete for mixing and quenching to obtain a quenched mixture. The quenching process requires maintaining a low temperature and stirring, with the saturated sodium bicarbonate solution added dropwise slowly until no more bubbles are generated and the pH of the aqueous phase stabilizes in the weakly alkaline range. The amount of quenching solution used is typically one to two times the volume of the reaction system.
[0032] Step S353: Allow the quenched mixture to stand and separate into layers, separating the upper aqueous phase and the lower organic phase. Since dichloromethane has a higher density than water, the organic phase is located in the lower layer. The two phases are separated using a separatory funnel or a separatory tank and collected separately.
[0033] Step S354 involves multiple extractions of the upper aqueous phase using dichloromethane to obtain the extracted organic phase. A small amount of the target product remains dissolved in the upper aqueous phase, which is recovered through dichloromethane extraction. This process is typically performed two to three times, with the amount of extractant used each time being one-third of the volume of the aqueous phase. The combined extracts constitute the extracted organic phase.
[0034] Step S355: Combine the lower organic phase and the extracted organic phase to obtain a combined organic phase. The combined organic phase is then washed, dried, and concentrated. Low-boiling-point impurities are removed by short-path distillation to determine the betaketone ester intermediate. The washing step typically involves one to two washes with saturated brine to remove residual bicarbonate and inorganic ions from the organic phase. Drying is performed using anhydrous magnesium sulfate or anhydrous sodium sulfate, with stirring for 30 minutes after addition and filtration to remove the drying agent. Concentration is carried out under reduced pressure, with the water bath temperature not exceeding 40°C to prevent enolization or decomposition of the betaketone ester intermediate at high temperatures. The crude product obtained from concentration usually contains a small amount of unreacted diazonium acetate and maleate ester byproducts formed after nitrogen release. These low-boiling-point impurities can be removed by short-path distillation under a vacuum of 0.01 MPa and an oil bath temperature of 80°C, yielding a high-purity betaketone ester intermediate, typically a pale yellow to orange oily liquid. It should be noted that the choice and amount of Lewis acid in the homologation reaction have a significant impact on the selectivity of the reaction. In one embodiment, if the biphenyl group of the aldehyde intermediate has a strong electron-withdrawing substituent such as a nitro or cyano group, the carbonyl group itself has high reactivity. In this case, zinc chloride, with its milder reactivity, is preferred, and a dosage of about 5% is sufficient to achieve a good conversion rate. If the biphenyl group has an electron-donating substituent such as a methoxy or methyl group, the carbonyl group has lower reactivity. A boron trifluoride diethyl ether complex needs to be selected, and its dosage increased to over 20% to ensure the reaction completes within a reasonable time. This strategy of flexibly adjusting the type and amount of Lewis acid based on the substrate structure enables the process to be universally applicable to different biphenyl derivatives, facilitating the switching of production of multiple target product classes on the same production line. For example, when tin tetrachloride is used as the Lewis acid, the system color gradually changes from light yellow to dark brown during the reaction. This is a characteristic of tin tetrachloride forming a complex with the carbene intermediate after nitrogen release. In such cases, an additional water washing step is required to ensure that the tin residue is reduced to below 10 parts per million, meeting the requirements for heavy metal residues in the synthesis of active pharmaceutical ingredients.
[0035] Step S4 involves obtaining a hydrazine compound. In a two-phase system consisting of an aqueous and an organic phase, a phase-transfer catalyst is used to induce a condensation reaction between the betaketone ester intermediate and the hydrazine compound, yielding a condensation intermediate with a tert-butyl carbamate protecting group. Here, the condensation reaction is the key step in constructing the target molecular skeleton. The essence of the reaction is that two adjacent nitrogen atoms in the hydrazine compound undergo nucleophilic addition and condensation with the ketone carbonyl group and ester group in the betaketone ester intermediate, respectively, resulting in the removal of two water molecules or one water molecule and one alcohol molecule, ultimately forming the target molecular structure. The reason for choosing a two-phase system consisting of an aqueous and an organic phase for the reaction is that the betaketone ester intermediate is a hydrophobic organic compound, while hydrazine hydrate has strong polarity and hydrophilicity. If an organic solvent system is used alone, the solubility of hydrazine hydrate in the organic phase is limited, resulting in a very slow reaction rate; if an aqueous system is used alone, the betaketone ester intermediate cannot be fully dissolved. The two-phase system, combined with a phase-transfer catalyst, enables the efficient migration of active hydrazine anions from the aqueous phase to the organic phase interface, where they react with beta-ketone ester intermediates, balancing reaction rate and selectivity. Furthermore, the formation of the target molecule involves two isomers: one- to three-position substitution and one- to five-position substitution. The ratio of these two isomers significantly influences the drug activity and purification difficulty of the final product. By rationally selecting the type of phase-transfer catalyst, the strength of the aqueous phase alkalinity, and the reaction temperature, the ratio of isomers can be effectively controlled, ensuring that the product with the target configuration dominates.
[0036] In one possible implementation, step S4 specifically includes the following sub-step: Step S41, obtaining at least one of tetrabutylammonium bromide, benzyltriethylammonium chloride, or octadecanoic acid as a phase transfer catalyst.
[0037] Tetrabutylammonium bromide is a commonly used quaternary ammonium salt phase transfer catalyst. Its molecular structure contains four butyl chains, which can form ion pairs with anions in the aqueous phase at the organic-aqueous phase interface, carrying them into the organic phase to participate in the reaction. Benzyltriethylammonium chloride has a relatively compact structure, suitable for reaction systems with low steric hindrance requirements, and its relatively low price makes it suitable for large-scale production. Octadectophodoacetic acid (OCA) belongs to the crown ether phase transfer catalyst class. Through its cavity structure, it selectively complexes potassium ions, thereby transferring hydroxide ions or active hydrazine anions from the potassium carbonate aqueous phase to the organic phase. The choice of these three catalysts depends on the specific requirements of the reaction system. Tetrabutylammonium bromide is usually the first choice, and its dosage is controlled between 5% and 10% of the molar amount of the beta-ketone ester intermediate.
[0038] Step S42: Obtain toluene or xylene as the organic phase and an alkaline aqueous solution containing sodium carbonate or potassium carbonate as the aqueous phase. Toluene is a commonly used organic solvent with a moderate boiling point and is immiscible with water. Its boiling point is approximately 110 degrees Celsius, which can meet the heating temperature requirements of the condensation reaction under normal pressure. Xylene has a higher boiling point, approximately 140 degrees Celsius, and is suitable for substrates with lower reactivity that require higher temperatures to promote the reaction. The alkaline aqueous solution serves two purposes: firstly, it maintains a weakly alkaline environment in the reaction system, neutralizing acidic byproducts generated during the reaction; secondly, carbonate ions can assist in removing water from the intermediate after the addition of beta-ketone esters and hydrazine, promoting cyclization closure. Sodium carbonate aqueous solution has a milder alkalinity, suitable for substrates sensitive to bases; potassium carbonate aqueous solution has a slightly stronger alkalinity, and potassium ions have better compatibility with crown ethers, making it a preferred choice when using 18-crown-6 as a phase transfer catalyst. The concentration of the alkaline aqueous solution is usually controlled between 10% and 20% by mass.
[0039] Step S43 involves mixing the beta-ketone ester intermediate with the organic phase, phase transfer catalyst, and aqueous phase to obtain a mixed system. The mixing process is carried out in the following order: first, the beta-ketone ester intermediate is dissolved in toluene to form an organic phase solution; then, the phase transfer catalyst is added and stirred to dissolve; finally, an alkaline aqueous solution is slowly injected to form a distinct two-phase system. To ensure sufficient contact between the two phases, the reactor is usually equipped with a high-speed stirring impeller, with the rotation speed controlled between 300 and 500 revolutions per minute, so that the two phases form a fine emulsion state but are not difficult to separate into layers.
[0040] Step S44 involves heating the mixture to a preset third temperature threshold. This third temperature threshold is typically set between 60 and 80 degrees Celsius, with the specific temperature determined based on the boiling point of the organic solvent and the volatility of the hydrazine compound. When toluene is chosen as the organic phase, the third temperature threshold is set to 70 degrees Celsius, which ensures a good reaction rate while preventing excessive loss of hydrazine hydrate due to volatilization. When xylene is chosen as the organic phase, the third temperature threshold can be appropriately increased to 80 degrees Celsius or higher. The heating process is carried out through a heat-conducting oil jacket outside the reactor, with the heating rate controlled within two degrees Celsius per minute to prevent localized overheating that could lead to enolization of the ketone carbonyl group in the beta-ketone ester intermediate.
[0041] Step S45: A hydrazine compound, specifically hydrazine hydrate, is added dropwise to the mixture at the third temperature threshold. Hydrazine hydrate is a colorless, fuming liquid with strong reducing properties and some toxicity, typically used as an 80% (w / w) aqueous solution. The dropwise addition is performed using a constant-pressure dropping funnel or a metering pump, with the addition time controlled between 30 minutes and one hour. The amount of hydrazine hydrate added is usually 1.1 to 1.3 times the molar amount of the beta-ketone ester intermediate. A slight excess of hydrazine hydrate helps to drive the reaction toward the cyclization product, but too much excess will create additional wastewater treatment burden in the post-processing. During the dropwise addition, the color of the reaction system can be observed to gradually deepen from light yellow to orange-yellow, which is a characterization of the gradual establishment of the conjugated structure during product formation.
[0042] Step S46: After the addition is complete, maintain the reaction at the third temperature threshold to determine the isomer ratio of the reaction system. If the isomer ratio reaches the preset threshold, separate the organic phase. Wash, dry, and concentrate the separated organic phase to identify the condensation intermediate with the tert-butyl carbamate protecting group. The reaction time is typically four to eight hours, with samples taken every hour for liquid chromatography analysis, focusing on the peak area ratio of the one- to three-position substituted and one- to five-position substituted isomers. When the proportion of the target isomer reaches at least 95%, the preset threshold is considered met, and the reaction can be terminated to proceed to the post-processing steps. If the proportion does not meet the target, the reaction time can be appropriately extended or a small amount of phase transfer catalyst can be added to promote the thermodynamic equilibrium of the isomers.
[0043] Further, the post-processing in step S46 specifically includes the following sub-steps: Step S461, using a preset extraction solvent to extract the aqueous phase after the reaction to obtain a supplementary organic phase. After the reaction, the system is first allowed to stand and separate into layers. The upper organic phase is separated for later use, while the lower aqueous phase still contains a small amount of the target product and water-soluble byproducts. The extraction solvent is usually ethyl acetate or dichloromethane, or toluene, the same solvent used in the main reaction, can be used. The extraction is performed two to three times, with the amount of extractant used each time being one-third of the volume of the aqueous phase. During the extraction process, stirring and standing are alternated to ensure that the product is fully transferred to the organic phase.
[0044] Step S462: Combine the separated organic phases with the supplementary organic phases to obtain the total organic phase. The combined total organic phase contains a condensation intermediate with a tert-butyl carbamate protecting group, trace amounts of phase transfer catalyst residue, small amounts of unreacted beta-ketone esters, and solvated carbonates.
[0045] Step S463 involves washing the total organic phase with saturated brine to obtain the washed organic phase. The purpose of washing with saturated brine is twofold: firstly, to break down any remaining emulsion layer through salting-out; and secondly, to wash out water-soluble quaternary ammonium salt phase-transfer catalysts into the aqueous phase, thereby reducing catalyst residue in the product. Washing is typically performed two to three times, with each wash solution containing one-third the volume of the organic phase, until the aqueous phase is neutral and clear.
[0046] Step S464 involves drying the washed organic phase with a desiccant to obtain a dried organic phase. Anhydrous magnesium sulfate or anhydrous sodium sulfate is typically chosen as the desiccant, used at 5% to 10% of the organic phase mass. After addition, the mixture is stirred at room temperature for at least 30 minutes. The dried desiccant solids are then removed using a filter press or suction funnel. The water content of the dried organic phase should be controlled below 200 parts per million to avoid incomplete hydrolysis or crystallization of the product due to the presence of water during subsequent vacuum concentration.
[0047] Step S465: The dried organic phase is concentrated under reduced pressure to obtain a crude solid product. The crude solid product is then recrystallized using a mixed solvent of ethanol and water to identify the condensation intermediate with a tert-butyl carbamate protecting group. Reduced pressure concentration is performed in a rotary evaporator or falling film evaporator at a vacuum of 0.08 MPa and a water bath temperature controlled below 45°C until the solvent distillation reaches the expected value, yielding a light yellow to beige crude solid product. The recrystallization process is as follows: the crude solid product is added to a mixed solvent of ethanol and water in a 3:1 volume ratio, heated to reflux to completely dissolve, then slowly cooled to room temperature and further cooled to 0-5°C for crystallization. The crystallization process lasts four to six hours. The precipitated crystals are collected by filtration, washed with a cold ethanol-water mixture, and finally dried in a vacuum drying oven at 40°C for at least eight hours to obtain white to off-white needle-like or flaky crystals. The purity of the product after recrystallization is typically above 99%, and the isomer ratio is further increased to above 99%, providing high-purity raw materials for subsequent deprotection steps. It should be noted that the choice of phase transfer catalyst in the condensation reaction directly affects the reaction rate and isomer distribution. In one embodiment, when tetrabutylammonium bromide is used as the phase transfer catalyst in conjunction with an aqueous sodium carbonate solution, the reaction can be completed in six hours at 70°C, achieving a target isomer ratio of 96%. In another embodiment, when 18-crown-6 is used in conjunction with an aqueous potassium carbonate solution, the reaction rate is significantly accelerated, achieving the same conversion rate in four hours, and the target isomer ratio can be increased to 98%. However, 18-crown-6 is expensive and difficult to recover, and is typically used in the synthesis of high-end pharmaceutical raw materials where isomer ratio requirements are extremely stringent. In yet another embodiment, when benzyltriethylammonium chloride is used in conjunction with an aqueous sodium carbonate solution, although the reaction rate is slightly lower, requiring eight hours to complete, the catalyst cost is lower and it is easily recovered through water washing, making it suitable for large-scale conventional production. For example, the choice of phase transfer catalyst also needs to be adjusted accordingly for beta-ketone ester intermediates with different biphenyl substituents. When the biphenyl group has a halogen substituent, the substrate polarity is slightly higher. In this case, benzyltriethylammonium chloride is preferred because its benzyl structure has a weak stacking interaction with the biphenyl group, which helps to enrich the substrate around the catalyst and improve reaction efficiency. When the biphenyl group has an alkoxy substituent, the substrate polarity is lower. In this case, tetrabutylammonium bromide is chosen because its long-chain alkyl structure has good compatibility with alkoxy substituents. This strategy of flexibly selecting catalysts based on substrate structure can keep the yield of the condensation step consistently above 85%. It can be understood that the condensation intermediate with a tert-butyl carbamate protecting group obtained through step S4 already possesses the complete skeleton structure of the target product, retaining only a tert-butyloxycarbonyl protecting group at the amino position. Subsequent removal of this protecting group under mild acidic conditions will yield the final target product.The intermediate is a stable solid at room temperature and can be stored in a sealed container for a long time, which facilitates scheduling between production batches and flexible arrangement of subsequent steps.
[0048] Step S5 involves deprotecting the condensation intermediate with a tert-butyl carbamate protecting group under acidic conditions to obtain the target product. Here, the deprotection reaction is the final step in the entire synthetic route. Its purpose is to remove the tert-butyl carbamate protecting group from the condensation intermediate, restoring the active amino functional group, thereby obtaining the final target product, the pharmaceutical intermediate or active pharmaceutical ingredient. The mechanism of tert-butyl carbamate protecting group removal is that under acidic conditions, the protonated tert-butyloxycarbonyl group undergoes intramolecular rearrangement, removing isobutylene and carbon dioxide, while releasing a free amino group. Because this reaction can be carried out under moderately acidic conditions and does not involve metal catalysts or reducing agents, it exhibits good orthogonal selectivity for substrates containing various sensitive functional groups such as biphenyl groups, amino groups, and hydroxyl groups, without destroying the structure of these functional groups. In one possible implementation, step S5 specifically includes the following sub-steps: Step S51, constructing acidic conditions by obtaining an ethyl acetate solution of hydrogen chloride or an ethanol solution of p-toluenesulfonic acid. Ethyl acetate solution of hydrogen chloride is a commonly used deprotecting agent, typically at a concentration of 4 mol / L. It offers advantages such as strong acidity, rapid reaction rate, and convenient post-treatment. After the reaction, hydrogen chloride can be directly removed by vacuum concentration, avoiding the presence of difficult-to-remove acidic impurities in the product. Ethanol solution of p-toluenesulfonic acid, on the other hand, belongs to the organic sulfonic acid class of acidic reagents. While its acidity is slightly weaker than hydrogen chloride, it is more mild and controllable, making it suitable for substrates sensitive to reaction conditions. Its concentration is typically prepared at 10% to 20% by mass. The choice between these two acidic conditions depends on a combination of substrate stability and the ease of subsequent purification. In most cases, ethyl acetate solution of hydrogen chloride is preferred to obtain a faster reaction rate.
[0049] Step S52 involves dissolving the condensation intermediate with the tert-butyl carbamate protecting group in a pre-selected reaction solvent to obtain a third solution. The reaction solvent is typically ethyl acetate, dichloromethane, or methanol. Ethyl acetate and its ethyl acetate solution (containing hydrogen chloride) share a common solvent system, facilitating the homogeneity of the reaction system. Dichloromethane is suitable for substrates sensitive to alcohols. Methanol is generally used when employing a p-toluenesulfonic acid ethanol solution. The dissolution process is carried out at room temperature or with a slight heating to 30 degrees Celsius, using magnetic or mechanical stirring to ensure complete dissolution of the intermediate, forming a homogeneous, transparent, pale yellow solution. The solution concentration is typically controlled between 0.1 g and 0.2 g per milliliter.
[0050] Step S53: Introduce an ethyl acetate solution of hydrogen chloride or an ethanol solution of p-toluenesulfonic acid into the third solution to obtain the fourth solution. The introduction process needs to be carried out at low temperature and under stirring. Typically, the reaction vessel is pre-cooled to below zero degrees Celsius, and then the acidic solution is slowly added through a constant-pressure dropping funnel. During the addition, there will be slight exothermic reactions and the initial release of carbon dioxide bubbles, which is an early characteristic of the protonation of the tert-butyloxycarbonyl group. The amount of acidic solution used is usually three to five times the molar amount of the condensation intermediate; an excess of acidic substance ensures complete deprotection. After the addition is complete, continue stirring for five to ten minutes to ensure the system is thoroughly mixed.
[0051] Step S54: The fourth solution is stirred and reacted at a preset fourth temperature threshold. This fourth temperature threshold is typically set to room temperature (20-30 degrees Celsius). Room temperature is chosen over high temperature because the deprotection reaction proceeds at a suitable rate at room temperature, and the low temperature helps suppress side reactions between the hydroxyl groups in the molecule and the acidic reagent. The stirring reaction time is typically three to six hours, during which isobutylene and carbon dioxide gases generated in the reaction are continuously discharged through the reactor's exhaust port. During the reaction, the solution color gradually deepens, changing from light yellow to dark yellow or light brown, and continuous bubbles can be observed accompanying the gas release.
[0052] Step S55: Determine the reaction progress of the fourth solution. If the reaction is complete, concentrate the fourth solution under reduced pressure to remove excess acidic substances. Add water and adjust the pH to weakly alkaline using an alkaline reagent. Obtain the crude product through extraction, drying, and concentration. Recrystallize the crude product to determine the target product. The reaction progress is determined by liquid chromatography or thin-layer chromatography, observing whether the residual peak of the condensation intermediate disappears and whether the product peak stabilizes and stops increasing. When the residual amount of the intermediate drops below 0.5%, the reaction is considered complete. Further, the post-processing of step S55 is subdivided into the following steps: Step S551: Reduced pressure concentration to remove excess acidic substances. Transfer the reaction solution to a rotary evaporator and concentrate it under a vacuum of 0.08 MPa and a water bath temperature of 35 degrees Celsius to evaporate the ethyl acetate solvent and most of the hydrogen chloride gas. During the concentration process, the emitted hydrogen chloride is absorbed by a tail gas absorption device with an aqueous sodium hydroxide solution to avoid corrosion of the environment and equipment. The concentrate obtained after concentration is usually a yellow, viscous, oily substance containing the hydrochloride form of the product and a small amount of residual solvent.
[0053] Step S552: Add water to dissolve the concentrate and adjust the pH. Add deionized water to the concentrate and stir to dissolve, forming an aqueous solution of the product hydrochloride. Typically, the amount of water used is five to ten times the mass of the concentrate. A small amount of insoluble matter may be present during dissolution, which can be removed by diatomaceous earth filtration. Then, under ice bath cooling and stirring, slowly add a saturated sodium bicarbonate aqueous solution or a 10% (w / w) sodium hydroxide aqueous solution until the system pH reaches a weakly alkaline range of 8 to 9. During alkalization, the product can be observed to precipitate from the aqueous phase as a free base, forming a white or light-colored suspension. The alkalization process needs to be carried out slowly to avoid localized over-alkaliness that could lead to decomposition of the target molecules.
[0054] Step S553: Obtain the product by extraction. Ethyl acetate or dichloromethane is added to the alkalized suspension for extraction, typically three times, with the extractant used each time being one-third the volume of the aqueous phase. The extracts are combined and washed once with saturated brine to remove residual inorganic salts and trace amounts of alkaline aqueous solution.
[0055] Step S554: Drying and concentration to obtain the crude product. The extract is dried with anhydrous magnesium sulfate at a rate of 5% of the extract mass. After stirring for 30 minutes, the drying agent is removed by filtration. The filtrate is concentrated under reduced pressure, with the water bath temperature controlled below 40 degrees Celsius. After all the solvent is evaporated, a light yellow to off-white solid crude product is obtained. The purity of the crude product is usually between 95% and 97%.
[0056] Step S555: Recrystallization to obtain the final product. The crude solid product is added to a recrystallization solvent, typically a mixture of ethanol and n-heptane in a 1:2 volume ratio, or a combination of isopropanol or ethyl acetate and n-hexane. The crude product is heated to the solvent reflux temperature to completely dissolve it, then hot-filtered to remove any insoluble impurities. The filtrate is slowly cooled to room temperature and then further cooled to 0-5 degrees Celsius for crystallization. Crystallization typically lasts six to twelve hours, with gentle stirring to obtain a uniform crystal form and particle size distribution. The precipitated crystals are collected by vacuum filtration, washed with a cold recrystallization solvent, and finally dried in a vacuum drying oven at 45 degrees Celsius for at least ten hours to obtain the target product as white needle-like or flaky crystals. The purity of the final recrystallized product is typically above 99.5%, with an enantiomeric excess value maintained above 99%, meeting the quality standards for pharmaceutical raw materials. It should be noted that the choice of acidic reagent in the deprotection reaction directly affects the yield and purity of the product. In one embodiment, a 4-molar-per-liter solution of ethyl hydrochloride is used as the acidic reagent, and deprotection is completed in four hours at room temperature, achieving a final product yield of over 90%, suitable for batch production with high reaction rate requirements. In another embodiment, a 15% (w / w) solution of p-toluenesulfonic acid in ethanol is used as the acidic reagent, extending the reaction time to six hours, but the chloride ion residue in the product is zero, making it particularly suitable for the synthesis of injectable active pharmaceutical ingredients sensitive to chloride residue. In yet another embodiment, if the substrate structure contains acid-sensitive functional groups, the reaction temperature can be further reduced to below 10 degrees Celsius, and the reaction time extended to 12 hours, sacrificing reaction rate for higher selectivity. For example, the operation method of the deprotection step can be flexibly adjusted to meet different production scale requirements. In small-scale laboratory trials, batch reactors with ice bath cooling are typically used, with reaction volumes ranging from a few liters. In pilot-scale production, a 100-liter reactor with jacketed temperature control and tail gas absorption systems is used, maintaining reaction stability through precise control of the dropping rate and stirring speed. In industrial production, a continuous flow reactor with an online neutralization device can be employed. The reaction solution is passed at a constant flow rate into the acidic reaction section and then directly into the alkaline neutralization section, achieving continuous operation from deprotection to neutralization, significantly shortening the production cycle and reducing energy consumption per batch. Specifically, the recrystallization step is crucial for ensuring the crystal form and purity of the final product. The target product often exists in multiple crystal forms, each with varying solubility, stability, and bioavailability. Therefore, selecting appropriate recrystallization solvents and controlling the crystallization temperature are necessary to obtain the target crystal form.In one embodiment, a stable methyl methacrylate (MCM) crystal is obtained using a mixed solvent of ethanol and n-heptane, with a melting point range of 165 to 168 degrees Celsius. The powder exhibits good flowability and is suitable for direct tablet compression. In another embodiment, if isopropanol is used as the recrystallization solvent, an ethyl methacrylate (EDM) crystal is obtained, with slightly higher solubility than MCM, suitable for the development of oral liquid formulations. Crystal form identification is typically performed simultaneously using powder diffraction and differential scanning calorimetry to ensure consistent crystal form across batches. It is understood that the complete synthetic route, consisting of steps S1 to S5, begins with a chiral amino alcohol containing a biphenyl group and a tert-butyl carbamate protecting group, and proceeds sequentially through selective oxidation in a continuous flow microchannel reactor, Lewis acid-catalyzed homogenization, phase transfer catalytic condensation in a two-phase system, and deprotection under acidic conditions, ultimately yielding a high-purity target product with a high enantiomeric excess. The overall yield of this process typically reaches over 65%, an improvement of approximately 20% compared to traditional batch processes, while reducing wastewater discharge by about 30%, meeting the dual requirements of green chemistry and industrialized production. In one embodiment, the above process is applied to a target product active pharmaceutical ingredient (API) production line with a daily output of hundreds of kilograms. A continuous flow microchannel reactor is used for the oxidation step, followed by two series-connected batch reactors for homogenization and condensation steps, respectively. Finally, deprotection and neutralization are completed in a continuous flow tubular reactor. The number of operators on this production line can be reduced to half that of traditional processes. Simultaneously, online infrared and liquid chromatography monitoring of key parameters at each step enables automated control of the entire production process. The batch-to-batch stability of the product quality is significantly improved, with impurity profiles remaining largely consistent, providing a stable and reliable raw material guarantee for downstream formulation development. In another embodiment, this process is applied to the synthesis of target product analogs with different biphenyl substituents. By adjusting the substituent structure of the starting material and the catalyst selection in corresponding steps, multiple target product derivatives can be flexibly switched on the same production line, including analogs with halogenated substituents, analogs with alkoxy substituents, and analogs with cyano substituents. Once the synthesis parameters for each analogue are determined through preliminary small-scale optimization, they can be directly scaled up to industrial scale, demonstrating the process's excellent versatility and portability. Preferably, solvents and reagents used in each step of the entire process are recycled through a recovery system. Dichloromethane in the oxidation step, dichloromethane in the homologation step, toluene in the condensation step, and ethyl acetate in the deprotection step are all separated and purified by distillation and returned to their respective processes for recycling. The solvent recovery rate can typically reach over 90%, significantly reducing the solvent consumption cost per unit product and minimizing the environmental impact of waste solvent emissions.
[0057] The above description of the embodiments is only for the purpose of helping to understand the technical solutions and core ideas of this application; those skilled in the art should understand that they can still modify the technical solutions described in the foregoing embodiments, or make equivalent substitutions for some of the technical features; and these modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of this application.
Claims
1. An industrial production process for biphenyl-substituted chiral amino alcohols, characterized in that, include: A chiral amino alcohol containing a biphenyl group and a tert-butyl carbamate protecting group is obtained as a starting material. The starting material is fed into a continuous flow microchannel reactor, and the primary hydroxyl group of the starting material is selectively oxidized through a preset catalytic oxidation system to obtain an aldehyde intermediate. A diazonium acetate compound is obtained, and the aldehyde intermediate is homogenized with the diazonium acetate compound under Lewis acid catalysis to obtain a betaketone ester intermediate. A hydrazine compound is obtained, and the betaketone ester intermediate is condensed with the hydrazine compound in a two-phase system consisting of an aqueous phase and an organic phase through a phase transfer catalyst to obtain a condensation intermediate with a tert-butyl carbamate protecting group. The condensation intermediate with the tert-butyl carbamate protecting group is deprotected under acidic conditions to obtain the target product.
2. The industrial production process for biphenyl-substituted chiral amino alcohols as described in claim 1, characterized in that, The selective oxidation of the primary hydroxyl group of the starting material to obtain an aldehyde intermediate via a preset catalytic oxidation system includes: obtaining tetramethylpiperidine nitride, hypochlorite, and bromide to construct the catalytic oxidation system; controlling the input of the starting material and the catalytic oxidation system into the mixing section of the continuous flow microchannel reactor to obtain a mixture; controlling the mixture in the reaction residence section of the continuous flow microchannel reactor within a preset temperature range and controlling the residence time of the mixture in the reaction residence section to reach a preset time threshold; obtaining the reaction liquid from the outlet of the continuous flow microchannel reactor, determining the stratification state of the liquid, and if the liquid exhibits a two-phase separation state, performing stratification treatment on the liquid to obtain an organic phase, and washing, drying, and concentrating the organic phase to determine the aldehyde intermediate.
3. The industrial production process of a biphenyl-substituted chiral amino alcohol as described in claim 1, characterized in that, The process of homogenizing the aldehyde intermediate with the diazonium acetate ester compound under Lewis acid catalysis to obtain a betaketone ester intermediate includes: obtaining at least one of boron trifluoride diethyl ether complex, zinc chloride, or tin tetrachloride as the Lewis acid; dissolving the aldehyde intermediate in a preset organic solvent under anhydrous conditions to obtain a first solution; adding the Lewis acid to the first solution to obtain a second solution; adding a solution of the diazonium acetate ester compound dropwise to the second solution, controlling the temperature of the dropwise addition process to be below a preset first temperature threshold; raising the temperature to a preset second temperature threshold after the dropwise addition is completed and maintaining the temperature for the reaction, judging the conversion rate of the reaction system, and if the conversion rate reaches a preset conversion rate threshold, adding an alkaline solution for quenching, separating and identifying the betaketone ester intermediate.
4. The industrial production process of a biphenyl-substituted chiral amino alcohol as described in claim 1, characterized in that, In the two-phase system consisting of an aqueous phase and an organic phase, the betaketone ester intermediate undergoes a condensation reaction with the hydrazine compound using a phase transfer catalyst to obtain a condensation intermediate with a tert-butyl carbamate protecting group. The process includes: obtaining at least one of tetrabutylammonium bromide, benzyltriethylammonium chloride, or octadecanoic acid as the phase transfer catalyst; obtaining toluene or xylene as the organic phase; obtaining an alkaline aqueous solution containing sodium carbonate or potassium carbonate as the aqueous phase; mixing the betaketone ester intermediate with the organic phase, the phase transfer catalyst, and the aqueous phase to obtain a mixed system; heating the mixed system to a preset third temperature threshold; adding the hydrazine compound, specifically hydrazine hydrate, dropwise to the mixed system at the third temperature threshold; maintaining the temperature at the third temperature threshold after the addition is complete; determining the isomer ratio of the reaction system; if the isomer ratio reaches a preset ratio threshold, separating the organic phase; washing, drying, and concentrating the separated organic phase to identify the condensation intermediate with the tert-butyl carbamate protecting group.
5. The industrial production process of a biphenyl-substituted chiral amino alcohol as described in claim 1, characterized in that, The process of deprotecting the condensation intermediate with a tert-butyl carbamate protecting group under acidic conditions to obtain the target product includes: constructing the acidic conditions by obtaining an ethyl acetate solution of hydrogen chloride or an ethanol solution of p-toluenesulfonic acid; dissolving the condensation intermediate with the tert-butyl carbamate protecting group in a preset reaction solvent to obtain a third solution; introducing the ethyl acetate solution of hydrogen chloride or the ethanol solution of p-toluenesulfonic acid into the third solution to obtain a fourth solution; controlling the fourth solution to be stirred at a preset fourth temperature threshold; judging the reaction progress of the fourth solution; if the reaction is completed, concentrating the fourth solution under reduced pressure to remove excess acidic substances, adding water and adjusting the pH to weakly alkaline using an alkaline reagent, obtaining a crude product through extraction, drying, and concentration, and recrystallizing the crude product to determine the target product.
6. The industrial production process of a biphenyl-substituted chiral amino alcohol as described in claim 2, characterized in that, The step of separating the feed solution into an organic phase, washing and drying the organic phase, and concentrating it to determine the aldehyde intermediate includes: controlling the feed solution to be fed into a separator and allowing it to stand and separate into a first organic phase and a first aqueous phase; using an extractant to perform countercurrent extraction on the first aqueous phase to obtain a second organic phase; combining the first organic phase and the second organic phase to obtain a third organic phase; washing the third organic phase with sodium thiosulfate solution, and then washing the washed third organic phase again with brine; drying the washed third organic phase with anhydrous sodium sulfate, and then concentrating the dried third organic phase under reduced pressure to determine the aldehyde intermediate.
7. The industrial production process of a biphenyl-substituted chiral amino alcohol as described in claim 4, characterized in that, The step of washing, drying, and concentrating the separated organic phase to determine the condensation intermediate with the tert-butyl carbamate protecting group includes: extracting the aqueous phase after the reaction using a preset extraction solvent to obtain a supplementary organic phase; combining the separated organic phase and the supplementary organic phase to obtain a total organic phase; washing the total organic phase with saturated brine to obtain a washed organic phase; drying the washed organic phase with a desiccant to obtain a dried organic phase; concentrating the dried organic phase under reduced pressure to obtain a crude solid product; and recrystallizing the crude solid product using a mixed solvent of ethanol and water to determine the condensation intermediate with the tert-butyl carbamate protecting group.
8. The industrial production process of a biphenyl-substituted chiral amino alcohol as described in claim 3, characterized in that, The step of quenching with an alkaline solution to separate and identify the betaketone ester intermediate includes: obtaining a saturated sodium bicarbonate solution as the alkaline solution; controlling the addition of the saturated sodium bicarbonate solution to the system after the reaction for mixing and quenching to obtain a quenched mixture; allowing the quenched mixture to stand and separate into layers, separating the upper aqueous phase and the lower organic phase; using dichloromethane to extract the upper aqueous phase multiple times to obtain an extracted organic phase; combining the lower organic phase and the extracted organic phase to obtain a combined organic phase; washing, drying, and concentrating the combined organic phase; and removing low-boiling-point impurities by short-path distillation to identify the betaketone ester intermediate.
